NEW DELHI/KUALA LUMPUR (Reuters): India has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of Covid-19 patients, Deputy Foreign Minister Kamarudin Jaffartold Reuters on Wednesday (April 15), with New Delhi partially lifting its bar on exports of the anti-malarial drug.
India is the world's largest producer of hydroxychloroquine, sales of which have soared across the world including in the United States, especially after President Donald Trump touted it as a potential weapon against Covid-19, the disease caused by the novel coronavirus.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
